Ref ID: 19576
Author:
SM Ignatyeva1*, VA Spiridonova1, OV Shadrivova1, YV Borzova1, EA Desyatik1, SN Khostelidi1,
AG Volkova2, MO Popova2, AS Kolbin3, IS Zjuzgin4, AV Klimovich5, NV Vasilyeva1,
LS Zubarovskaja2, BV Afanasyev2, NN Klimko1
Author address:
1Kashkin Research Institute of Medical Mycology, I.Metchnikov North-Western State Medical University,
Saint-Petersburg, Russia
2R. Gorbacheva Institute of Children’s Hematology and Transplantology, Saint-Petersburg, Russia
3Pediatric City Hospital
Full conference title:
6th Advances Against Aspergillosis 2014
Abstract:
Purpose:
To analyze the utility of galactomannan (GM) test for the diagnosis of invasive aspergillosis (IA) in
different groups patients with hematological malignancies in St. Petersburg, Russia.
Methods:
The study included 651 samples: 390 serum and 261 bronchoalveolar lavage fluid (BAL) from 360
hematological patients (313 specimens of neutropenic patients and 338 specimens of bone marrow
transplant recipients) with IA in Saint-Petersburg between 1998 and 2013 yy. Diagnosis of IA was
based on EORTC/MSG 2008 criteria. Detection of GM was performed with “œPlatelia Aspergillus
EIA” (Bio-Rad Laboratories). As controls, 216 samples were collected from the hematological
patients without IA. The test was considered as positive with cut-off of ≥ 0,5 (serum) and ≥ 1,0
(BAL). We calculated the sensitivity, specificity, positive predictive value and negative predictive
value for the GM assay. Two-tailed p values of “¹ 0,05 were considered statistically significant.
Results:
The patients were: adult – 84%, children – 16%. The mean age of patients was 37 years (range 1-77),
male – 54%, female – 46%. Sensitivity of GM test in adult neutropenic patients and in bone marrow
transplant recipients was identical (72% vs.73%). Positive results of GM test in BAL specimens of
neutropenic children with IA was revealed more often, than at bone marrow transplant recipients
group (91% vs. 63%, P=0,002). In neutropenic patients with IA a higher level GM index (2, 0 – 7, 5)
was found in the BAL samples more frequently in children, than in adult (60% vs. 23%, P=0,012)
and was similar in different groups bone marrow transplant recipients. The prognostic value of
positive and negative result of the GM test in serum samples of neutropenic patients and bone
marrow transplant recipients were 0,77 (95%CI 0,71-0,87) and 0,86 (95%CI 0,83-0,88), in BAL
samples – 0,85 (95%CI 0,79-0,94) and 0,84 (95%CI 0,78-0,96), respectively.
Conclusion:
This study indicates that sensitivity, prognostic value of positive and negative result of GM test in
neutropenic patients and in bone marrow transplant recipients depends on the type of biological
specimen and varies for adult and children.
Abstract Number: 102
Conference Year: 2014
Link to conference website: http://www.AAA2014.org
New link: NULL
Conference abstracts, posters & presentations
-
Title
Author
Year
Number
Poster
-
v
Teclegiorgis Gebremariam [MS]1, Yiyou Gu [PhD]1, Sondus Alkhazraji [PhD]1, Jousha Quran1, Laura K. Najvar [BS]2, Nathan P. Wiederhold [PharmD]2, Thomas F. Patterson [MD]2, Scott G. Filler [MD]1,3, David A. Angulo (MD)4, Ashraf S. Ibrahim [PhD]1,3*,
2024
91
n/a
-
v
Ruta Petraitiene (US)
2024
90
n/a
-
v
Fabio Palmieri (CH), Junier Pilar
2024
89
n/a
-
v
Evelyne Côté (CA)
2024
88
n/a
-
v
Eliane Vanhoffelen (BE)
2024
87
n/a
-
v
Teclegiorgis Gebremariam, Yiyou Gu, Eman Youssef, Sondus Alkhazraji, Joshua Quran, Nathan P. Wiederhold, Ashraf S. Ibrahim
2024
86
n/a
-
v
Thomas Orasch (DE)
2024
85
n/a
-
v
Julien Alex, Katherine González, Gauri Gangapurwala, Antje Vollrath, Zoltán Cseresnyés, Christine Weber, Justyna A. Czaplewska, Stephanie Hoeppener, Carl-Magnus Svensson, Thomas Orasch, Thorsten Heinekamp, Carlos Guerrero-Sánchez, Marc Thilo Figge, Ulrich S. Schubert, Axel A. Brakhage
2024
84
n/a
-
v
Vasireddy Teja, Bibhuti Saha Hod, Soumendranath Haldar (IN)
2024
83
n/a
-
v
Vasireddy Teja, Bibhuti Saha Hod, Soumendranath Haldar (IN)
2024
82
n/a